Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: a randomized controlled trial.

[1]  L. Pardo,et al.  Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial) , 2017, Trials.

[2]  S. Pasmans,et al.  Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with the Topical Endolysin Staphefekt SA.100: A Report of 3 Cases , 2017, Case Reports in Dermatology.

[3]  S. Pasmans,et al.  Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta‐analysis , 2016, The British journal of dermatology.

[4]  M. Blaser,et al.  Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. , 2016, Journal of the American Academy of Dermatology.

[5]  S. B. Ang,et al.  Use of emollients in atopic dermatitis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  D. Zillikens,et al.  A randomized, investigator‐blinded efficacy assessment study of stand‐alone emollient use in mild to moderately severe atopic dermatitis flares , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  R. Baba,et al.  Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia , 2013, The Journal of dermatology.

[8]  H. Williams,et al.  Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review , 2010, The British journal of dermatology.

[9]  T. Werfel,et al.  Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities , 2008, Experimental dermatology.